| Title | Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates. | | Author(s) | Feldman DM, Carbone J, Belden L, Borgida AF, Herson V | | Institution | Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Hartford Hospital, Hartford, CT, USA. | | Source | Am J Obstet Gynecol 2007 Sep; 197(3):284.e1-4. | | MeSH | Adult
Betamethasone
Bronchopulmonary Dysplasia
Dexamethasone
Female
Glucocorticoids
Humans
Infant, Newborn
Infant, Very Low Birth Weight
Pregnancy
Premature Birth
Prenatal Exposure Delayed Effects
Respiratory Distress Syndrome, Newborn
Retrospective Studies
| | Abstract | OBJECTIVE: The purpose of this study was to compare neonatal outcomes in very-low-birthweight infants who were exposed to antenatal betamethasone vs dexamethasone.
STUDY DESIGN: We reviewed all inborn very-low-birthweight infants from January 1997 through February 2006. Maternal medical records were reviewed to determine the type of antenatal steroids that each patient received; neonatal outcomes were compared using chi-square and Student t tests.
RESULTS: There were 334 very-low-birthweight infants who met the criteria for evaluation: 186 infants received betamethasone, and 148 infants received dexamethasone. There were no differences in race, gestational age at delivery, or mean birthweight between the 2 groups. There were significantly lower rates of respiratory distress syndrome and bronchopulmonary dysplasia in the betamethasone group, compared with the dexamethasone group. Other neonatal outcomes were similar in both groups.
CONCLUSION: Antenatal betamethasone was associated with a significantly lower rate of pulmonary complications caused by prematurity, when compared with dexamethasone. | | Language | eng | | Pub Type(s) | Comparative Study
Journal Article
| | PubMed ID | 17826422 |
|
